676-Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Irvine, Alan D. [1 ]
Paller, Amy S. [2 ,3 ]
Hamon, Sara [4 ]
Horowitz, Julie [4 ]
Farrell, Annamaria [4 ]
Hatsell, Sarah [4 ]
Ehmann, Peter [4 ]
Rodriguez Marco, Ainara [5 ]
Bansal, Ashish [4 ]
Chen, Zhen [4 ]
Levy, Stephane [4 ]
Cyr, Sonya L. [4 ]
机构：
[1] Trinity Coll Dublin, Dublin, Ireland
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Madrid, Spain
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; pediatric; bone alkaline phosphatase; dupilumab;
D O I：
10.1093/bjd/ljae266.050
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
676
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids
    Perala, Miia
    Ahola, Maria
    Mikkola, Tytti
    Pelkonen, Anna S.
    Remitz, Anita
    Makela, Mika J.
    ACTA PAEDIATRICA, 2020, 109 (03) : 550 - 556
  • [42] Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Praestgaard, Amy
    Prescilla, Randy
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [43] Dupilumab treatment normalizes skin barrier function in children aged 6-11 years with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Leung, Donald
    Ong, Peck
    Danby, Simon
    Ramirez-Gama, Marco
    Garcia, Shannon
    Patricia, Taylor
    Byers, Rob
    Matcher, Stephen
    Zahn, Joseph
    Bologna, Gabriel
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I30 - I30
  • [44] Hematologic laboratory parameters in adults and children aged 6 months to 18 years with moderate-to-severe atopic dermatitis treated with dupilumab
    Paller, Amy S.
    Siegfried, Elaine C.
    Khokhar, Faisal A.
    Gonzalez, Tayler
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 567 - 567
  • [45] Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
    Colonna, Cristiana
    Monzani, Nicola A.
    Quattri, Eleonora
    Montefusco, Francesca
    Cavalli, Riccardo
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (06) : 694 - 695
  • [46] Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Simpson, E. L.
    Hong, H. C.
    Marcoux, D.
    Chen, Z.
    Bego-Le Bagousse, G.
    Wang, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E121 - E122
  • [47] Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, Amy S.
    Simpson, Eric L.
    Beck, Lisa A.
    Hong, H. Chih-Ho
    Marcoux, Danielle
    Chen, Zhen
    Shumel, Brad
    Bansal, Ashish
    Rossi, Ana B.
    Chao, Jingdong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB139 - AB139
  • [48] Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study
    Vedie, Anne-Laure
    Ezzedine, Khaled
    Amazan, Emmanuelle
    Boralevi, Franck
    Milpied, Brigitte
    Taieb, Alain
    Seneschal, Julien
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 802 - 806
  • [49] Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry
    Haft, Michael A.
    Knapp, Keith D.
    Claxton, Ami
    Munoz, Breda
    Crawford, Julie M.
    Balu, Sanjeev
    Kim, Yestle
    Schneider, Shannon
    Eichenfield, Dawn Z.
    Silverberg, Jonathan I.
    Eichenfield, Lawrence F.
    Bagel, Jerry
    Rhoads, Jamie L. W.
    Paller, Amy S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (12) : 2057 - 2066
  • [50] Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Gooderham, Melinda
    Pariser, David M.
    Simpson, Eric L.
    Etoh, Takafumi
    Chen, Zhen
    Sierka, Debra
    Shumel, Brad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB118 - AB118
12345